3.82 -0.05(-1.30%)07/03/2024
AC Immune SA (ACIU)
AC Immune SA (ACIU)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| AC Immune to Present at the Jefferies Global Healthcare Conference in June 2024 | 05/28 07:00 | globenewswire.com |
| Alzheimer's vaccine licensing deal boosts AC Immune | 05/13 08:47 | marketwatch.com |
| Why Is AC Immune (ACIU) Stock Up 45% Today? | 05/13 08:13 | investorplace.com |
| AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update | 05/13 06:05 | globenewswire.com |
| AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's Disease | 05/13 06:00 | globenewswire.com |
| AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update | 03/14 07:00 | globenewswire.com |
| AC Immune Announces Upcoming Presentations at AD/PD™ 2024 | 02/22 07:00 | globenewswire.com |
| Down -35.7% in 4 Weeks, Here's Why AC Immune (ACIU) Looks Ripe for a Turnaround | 01/30 10:37 | zacks.com |
| AC Immune to Regain Global Rights to Crenezumab and Semorinemab | 01/22 07:00 | globenewswire.com |